Who makes Eliquis in the USA? Eliquis, also known as apixaban, is a prescription medication used to prevent blood clots in patients with atrial fibrillation (AFib), deep vein thrombosis (DVT), and pulmonary embolism (PE). It is produced by a well-known pharmaceutical company that has a strong presence in the United States.
Eliquis is manufactured by Bristol Myers Squibb, a global biopharmaceutical company that specializes in the development and production of innovative medications. Based in New Jersey, the company has a long-standing reputation for producing high-quality drugs that address a wide range of medical conditions. In the case of Eliquis, Bristol Myers Squibb has made significant strides in the field of anticoagulation therapy, providing patients with a safe and effective alternative to traditional blood thinners.
The production of Eliquis in the USA is a testament to the company’s commitment to providing American patients with access to cutting-edge treatments. By manufacturing the drug domestically, Bristol Myers Squibb ensures that the highest standards of quality and safety are maintained throughout the entire production process. This not only benefits patients but also supports the local economy and the pharmaceutical industry as a whole.
In addition to Eliquis, Bristol Myers Squibb has a diverse portfolio of medications that cater to various medical needs. The company’s dedication to research and development has led to the approval of several new drugs, making it a leader in the pharmaceutical industry. As for Eliquis, the drug has been well-received by both healthcare professionals and patients, thanks to its effectiveness and ease of use.
In conclusion, Eliquis is produced by Bristol Myers Squibb, a leading pharmaceutical company with a strong presence in the United States. By manufacturing the drug domestically, the company ensures that patients have access to a high-quality, innovative treatment option for various blood clot-related conditions.
